Shares of Silicon Laboratories (NASDAQ:SLAB) have received an average recommendation of “Hold” from the fourteen research firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $105.10.

A number of research analysts recently weighed in on the stock. Loop Capital decreased their target price on shares of Silicon Laboratories to $110.00 and set a “hold” rating for the company in a research report on Thursday, July 26th. B. Riley raised their target price on shares of Silicon Laboratories to $123.00 and gave the company a “buy” rating in a research report on Wednesday, July 25th. BidaskClub raised shares of Silicon Laboratories from a “strong sell” rating to a “sell” rating in a research report on Tuesday. MKM Partners decreased their target price on shares of Silicon Laboratories to $85.00 and set a “neutral” rating for the company in a research report on Friday, October 26th. Finally, Zacks Investment Research raised shares of Silicon Laboratories from a “hold” rating to a “buy” rating and set a $107.00 target price for the company in a research report on Tuesday, July 31st.

Silicon Laboratories stock traded down $2.04 during mid-day trading on Monday, reaching $84.37. The company’s stock had a trading volume of 276,022 shares, compared to its average volume of 399,006. The company has a market cap of $3.71 billion, a P/E ratio of 35.90, a price-to-earnings-growth ratio of 2.07 and a beta of 1.60. Silicon Laboratories has a 12 month low of $75.89 and a 12 month high of $110.70. The company has a current ratio of 5.44, a quick ratio of 4.91 and a debt-to-equity ratio of 0.34.

Silicon Laboratories (NASDAQ:SLAB) last released its earnings results on Wednesday, October 24th. The semiconductor company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.98 by $0.03. The business had revenue of $230.20 million during the quarter, compared to the consensus estimate of $227.36 million. Silicon Laboratories had a net margin of 7.45% and a return on equity of 12.48%. The firm’s revenue for the quarter was up 15.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.90 earnings per share. On average, equities research analysts forecast that Silicon Laboratories will post 2.77 EPS for the current year.

In other Silicon Laboratories news, SVP Alessandro Piovaccari sold 1,607 shares of the stock in a transaction on Wednesday, August 15th. The shares were sold at an average price of $94.50, for a total value of $151,861.50. Following the completion of the sale, the senior vice president now owns 31,074 shares in the company, valued at $2,936,493. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Sumit Sadana sold 5,500 shares of the stock in a transaction on Monday, August 13th. The shares were sold at an average price of $95.56, for a total transaction of $525,580.00. Following the completion of the sale, the director now owns 5,313 shares of the company’s stock, valued at approximately $507,710.28. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,916 shares of company stock valued at $1,015,797. Corporate insiders own 1.96% of the company’s stock.

Hedge funds have recently made changes to their positions in the business. Frontier Capital Management Co. LLC lifted its stake in shares of Silicon Laboratories by 310.3% during the 3rd quarter. Frontier Capital Management Co. LLC now owns 551,776 shares of the semiconductor company’s stock worth $50,653,000 after buying an additional 417,299 shares during the last quarter. Eagle Asset Management Inc. lifted its stake in shares of Silicon Laboratories by 54.0% during the 2nd quarter. Eagle Asset Management Inc. now owns 511,076 shares of the semiconductor company’s stock worth $50,903,000 after buying an additional 179,120 shares during the last quarter. Advisors Asset Management Inc. lifted its stake in shares of Silicon Laboratories by 7,462.3% during the 2nd quarter. Advisors Asset Management Inc. now owns 159,187 shares of the semiconductor company’s stock worth $224,000 after buying an additional 157,082 shares during the last quarter. FMR LLC lifted its stake in shares of Silicon Laboratories by 1.2% during the 2nd quarter. FMR LLC now owns 6,484,660 shares of the semiconductor company’s stock worth $645,872,000 after buying an additional 75,633 shares during the last quarter. Finally, Price Wealth Management Inc. acquired a new stake in shares of Silicon Laboratories during the 3rd quarter worth about $6,190,000. Hedge funds and other institutional investors own 91.37% of the company’s stock.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, designs, develops, and markets mixed-signal integrated circuits (ICs) in the United States, China, and internationally. The company offers Internet of things products, such as 8-bit mixed-signal, 32-bit wireless, and ultra-low-power 32-bit microcontrollers; wireless connectivity devices, including multiprotocol wireless Gecko system-on-chip devices; real-time operating systems; sensor products comprising optical, relative humidity/temperature, and hall effect magnetic sensors.

Further Reading: S&P 500 Index

Analyst Recommendations for Silicon Laboratories (NASDAQ:SLAB)

Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.